|
CUL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.557000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.570390E-02 |
| Normal-vs-Stage2 |
5.892800E-01 |
| Normal-vs-Stage3 |
2.181900E-03 |
| Normal-vs-Stage4 |
1.378870E-04 |
| Stage1-vs-Stage2 |
2.899400E-01 |
| Stage1-vs-Stage3 |
1.894390E-01 |
| Stage1-vs-Stage4 |
2.820400E-02 |
| Stage2-vs-Stage3 |
8.434000E-02 |
| Stage2-vs-Stage4 |
3.081800E-02 |
| Stage3-vs-Stage4 |
4.795600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.235700E-03 |
| Normal-vs-AfricanAmerican |
6.323000E-01 |
| Normal-vs-Asian |
2.259800E-02 |
| Caucasian-vs-AfricanAmerican |
3.334400E-01 |
| Caucasian-vs-Asian |
8.872400E-01 |
| AfricanAmerican-vs-Asian |
2.844800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.184100E-03 |
| Normal-vs-Female |
7.956100E-03 |
| Male-vs-Female |
5.197600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.191600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.342700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.957900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.253500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.020200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.741000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.469800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.120200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.176400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.533400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.860400E-03 |
| Classical-VS-Follicular |
7.154000E-02 |
| Classical-VS-Other |
3.486000E-01 |
| Classical-VS-Normal |
1.210160E-01 |
| Tall-VS-Follicular |
2.279400E-01 |
| Tall-VS-Other |
6.558400E-01 |
| Tall-VS-Normal |
3.241400E-04 |
| Follicular-VS-Other |
8.635000E-01 |
| Follicular-VS-Normal |
9.080500E-03 |
| Other-VS-Normal |
1.082410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.001900E-03 |
| Normal-vs-N1 |
1.353930E-04 |
| N0-vs-N1 |
6.289500E-02 |
|
|
